Cargando…
STK3 is a therapeutic target for a subset of acute myeloid leukemias
Acute myeloid leukemia (AML) is characterized by uncontrolled proliferation and accumulation of immature myeloblasts, which impair normal hematopoiesis. While this definition categorizes the disease into a distinctive group, the large number of different genetic and epigenetic alterations actually s...
Autores principales: | Camgoz, Aylin, Paszkowski-Rogacz, Maciej, Satpathy, Shankha, Wermke, Martin, Hamann, Martin V., von Bonin, Malte, Choudhary, Chunaram, Knapp, Stefan, Buchholz, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986655/ https://www.ncbi.nlm.nih.gov/pubmed/29876001 http://dx.doi.org/10.18632/oncotarget.25238 |
Ejemplares similares
-
Comparative RNAi Screens in Isogenic Human Stem Cells Reveal SMARCA4 as a Differential Regulator
por: Güneş, Ceren, et al.
Publicado: (2019) -
RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with DNMT3A Mutations
por: Sidorova, Olga Alexandra, et al.
Publicado: (2022) -
In Vivo Expansion of Co-Transplanted T Cells Impacts on Tumor Re-Initiating Activity of Human Acute Myeloid Leukemia in NSG Mice
por: von Bonin, Malte, et al.
Publicado: (2013) -
From RNAi Screens to Molecular Function in Embryonic Stem Cells
por: Ding, Li, et al.
Publicado: (2011) -
PhenoFam-gene set enrichment analysis through protein structural information
por: Paszkowski-Rogacz, Maciej, et al.
Publicado: (2010)